Research Article
The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens
Table 4
Analysis of genotype and acetylation status in BC patients.
| | Genotype | Acetylation status | (%) | | NAT2 |
| | Fast | 8 (8.8) | | Fast | 11 (12.1) | | Intermediate | 17 (18.7) | | Intermediate | 1 (1.0) | | Slow | 16 (17.6) | | Slow | 26 (28.6) | | Slow | 3 (3.3) | | Slow | 4 (4.4) | | Slow | 5 (5.5) |
|
|
